Liu Cheng

Estrella Immunopharma, Inc. · Chief Executive Officer

Liu Cheng is listed in filings as Chief Executive Officer at Estrella Immunopharma, Inc.. This profile follows SEC Form 4 activity through Feb 14, 2025, including 2 public disclosures. Recent filings connect the profile to Estrella Immunopharma, Inc. (ESLA). The current snapshot covers public activity from Feb 14, 2025. Reported amounts are shown as $415.0K to $400.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.